← Eichor
Condition: Soft Tissue Sarcoma Adult Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Soft Tissue Sarcoma Adult

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Phase 1/Phase 2 · 128 location(s) · University of Birmingham · NCT04625907Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumo
Phase 1/Phase 2 · 71 location(s) · Merck Sharp & Dohme LLC · NCT06395103The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Phase N/A · 22 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06408441Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biologica
Phase N/A · 5 location(s) · National Cancer Institute (NCI) · NCT01109394Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With
Phase 1/Phase 2 · 10 location(s) · Anocca AB · NCT07145450A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Phase 1/Phase 2 · 1 location(s) · Blueprint Medicines Corporation · NCT07629960Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
Phase 1 · 1 location(s) · Stanford University · NCT06500819Intravital Microscopy in Human Solid Tumors
NA · 1 location(s) · Mayo Clinic · NCT03823144Navigation Intervention for Adolescent and Young Adult Cancer Survivors
NA · 1 location(s) · Kaiser Permanente · NCT07406087Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT06198296Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
NA · 1 location(s) · University Hospital Tuebingen · NCT06385288Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration
Phase 2 · 4 location(s) · UNICANCER · NCT07192068Digital Peer Navigation for Adolescents and Young Adults With Cancer
NA · 1 location(s) · University Health Network, Toronto · NCT06193369Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Phase 1/Phase 2 · 22 location(s) · Milton S. Hershey Medical Center · NCT06541262Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patient
NA · 1 location(s) · University of Miami · NCT07359911Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Phase 2 · 4 location(s) · Niels Junker · NCT05961761Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT02701153Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
Phase 2 · 10 location(s) · Institut Bergonié · NCT05182164Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
Phase N/A · 10 location(s) · Azienda Ospedaliera Ospedale Infantile Regina Margherita San · NCT04621201Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Phase 1 · 3 location(s) · BioEclipse Therapeutics · NCT04282044Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
Phase 2 · 5 location(s) · Italian Sarcoma Group · NCT07328425Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT07675967FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06865664DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Phase 2/Phase 3 · 17 location(s) · Cancer Research UK · NCT06988475Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the
Phase 2 · 1 location(s) · Centre Oscar Lambret · NCT07507773Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.
Phase 2 · 2 location(s) · Oslo University Hospital · NCT07173972Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcom
Phase 2 · 2 location(s) · M.D. Anderson Cancer Center · NCT05019703Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168The Sarcoma Biology and Outcome Project
Phase N/A · 1 location(s) · Prof. Dr. Richard F Schlenk · NCT04758325Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Phase 1/Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT04577014
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.